The purpose of this pilot study is to generate preliminary data on the impact of the dietary protein pattern on markers of skeletal muscle health and drug efficacy in Parkinson disease.
Age range
45 Years – 99 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change in Markers of Skeletal Muscle Metabolism GDF15
Timeframe: Baseline to 5 weeks
Change in Markers of Skeletal Muscle Metabolism FGF21
Timeframe: Baseline to 5 weeks
Change in Handgrip Strength
Timeframe: Baseline to 5 weeks
Change in Sleep Efficiency
Timeframe: Baseline to 5 weeks
Change in Motor Symptoms
Timeframe: Baseline to 5 weeks